Europe Bioreactors Market Size By Technology (Wave-induced Motion SUB, Stirred SUB, Single Use Bubble Column), By Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), By End-use (R&D Organizations, Biopharma Manufacturers, CMOs), By Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Industry Analysis Report, Country Outlook (Germany, UK, Spain, Italy, France, The Netherlands, Denmark, Russia, Poland, Sweden, Norway), Application Potential, Competitive Market Share & Forecast, 2018 - 2025

Published Date: June 2019 | Publisher: Graphical Research Report ID: GR1233 | Delivery : PDF

Report Content

Chapter 1.   Methodology

1.1.   Definition and forecast parameters

1.1.1.  Definitions

1.1.2.  Methodology and forecast parameters        

1.2.   Data sources 

1.3.   References & sources

1.3.1.  Secondary

1.3.2.  Primary

Chapter 2.   Executive Summary

2.1.   Europe bioreactors industry summary, 2014 – 2025

2.1.1.  Country trends

2.1.2.  Cell trends

2.1.3.  Molecule trends

2.1.4.  Technology trends

2.1.5.  End-use trends

Chapter 3.   Industry Insights

3.1.   Industry segmentation

3.2.   Industry outlook, 2014 - 2025

3.3.   Major factor analysis

3.3.1.  Drivers

3.3.1.1.   Growing biopharmaceuticals and biologics industry

3.3.1.2.   Technological advancements in bioreactors

3.3.1.3.   Growing orphan drugs developments

3.3.1.4.   Increasing demand for personalized medicines

3.3.2.  Restraints & challenges

3.3.2.1.   Low capacity of single-use bioreactor

3.3.2.2.   Concerns regarding extractables and/or leachable

3.4.   Regulatory landscape

3.4.1.  Germany

3.4.2.  UK

3.5.   Technology landscape

3.6.   Porter’s analysis

3.7.   Competitive review, 2017

3.8.   PEST analysis

Chapter 4.   Europe Bioreactors Market, By Cell

4.1.   Key trends in Europe bioreactors, by cell

4.2.   Mammalian cells

4.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.3.   Bacterial cells

4.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.4.   Yeast cells

4.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

4.5.   Others

4.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 5.   Europe Bioreactors Market, By Molecule

5.1.   Key trends in Europe bioreactors, by molecule

5.2.   Monoclonal antibodies

5.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.3.   Vaccines

5.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.4.   Recombinant protein

5.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.5.   Stem cell

5.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.6.   Gene therapy

5.6.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

5.7.   Others

5.7.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 6.   Europe Bioreactors Market, By Technology

6.1.   Key trends in Europe bioreactors, by technology

6.2.   Wave-induced motion SUB

6.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

6.3.   Stirred SUB

6.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

6.4.   Stirred-use bubble column

6.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

6.5.   Others

6.5.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 7.  Europe Bioreactors Market, By End-use

7.1.   Key trends in Europe bioreactors, by end-use

7.2.   Research and development (R&D) organizations

7.2.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.3.   Biopharma manufacturers

7.3.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.4.   Contract manufacturing organizations (CMOs)

7.4.1.  Market estimates and forecast, by country, 2014 – 2025 (USD Million)

Chapter 8.   Europe Bioreactors Market, By Country

8.1.   Key trends in Europe bioreactors, by country

8.2.   Germany

8.2.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.2.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.2.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.2.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.2.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.3.   UK

8.3.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.3.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.3.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.3.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.3.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.4.   Spain

8.4.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.4.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.4.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.4.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.4.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.5.   Italy

8.5.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.5.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.5.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.5.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.5.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.6.   France

8.6.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.6.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.6.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.6.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.6.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.7.   The Netherlands

8.7.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.7.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.7.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.7.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.7.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.8.   Denmark

8.8.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.8.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.8.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.8.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.8.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.9.   Russia

8.9.1.   Market estimates and forecast, 2014 – 2025 (USD Million)

8.9.2.   Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.9.3.   Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.9.4.   Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.9.5.   Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.10. Poland

8.10.1. Market estimates and forecast, 2014 – 2025 (USD Million)

8.10.2. Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.10.3. Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.10.4. Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.10.5. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.11. Sweden

8.11.1. Market estimates and forecast, 2014 – 2025 (USD Million)

8.11.2. Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.11.3. Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.11.4. Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.11.5. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

8.12. Norway

8.12.1. Market estimates and forecast, 2014 – 2025 (USD Million)

8.12.2. Market estimates and forecast, by cell, 2014 – 2025 (USD Million)

8.12.3. Market estimates and forecast, by molecule, 2014 – 2025 (USD Million)

8.12.4. Market estimates and forecast, by technology, 2014 – 2025 (USD Million)

8.12.5. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

Chapter 9.   Company Profiles

9.1.   Applikon Biotechnology, Inc.

9.1.1.  Business overview

9.1.2.  Financial data

9.1.3.  Product landscape

9.1.4.  Strategic outlook

9.1.5.  SWOT analysis

9.2.   Bbi-biotech

9.2.1.  Business overview

9.2.2.  Financial data

9.2.3.  Product landscape

9.2.4.  Strategic outlook

9.2.5.  SWOT analysis

9.3.   Cellexus Limited

9.3.1.  Business overview

9.3.2.  Financial data

9.3.3.  Product landscape

9.3.4.  Strategic outlook

9.3.5.  SWOT analysis

9.4.   CerCell Aps

9.4.1.  Business overview

9.4.2.  Financial data

9.4.3.  Product landscape

9.4.4.  Strategic outlook

9.4.5.  SWOT analysis

9.5.   Eppendorf AG

9.5.1.  Business overview

9.5.2.  Financial data

9.5.3.  Product landscape

9.5.4.  Strategic outlook

9.5.5.  SWOT analysis

9.6.   GE Healthcare

9.6.1.  Business overview

9.6.2.  Financial data

9.6.3.  Product landscape

9.6.4.  Strategic outlook

9.6.5.  SWOT analysis

9.7.   GEA Group Aktiengesellschaft

9.7.1.  Business overview

9.7.2.  Financial data

9.7.3.  Product landscape

9.7.4.  Strategic outlook

9.7.5.  SWOT analysis

9.8.   Merck Group

9.8.1.   Business overview

9.8.2.   Financial data

9.8.3.   Product landscape

9.8.4.   Strategic outlook

9.8.5.   SWOT analysis

9.9.   Pierre Guerin Sas

9.9.1.   Business overview

9.9.2.   Financial data

9.9.3.   Product landscape

9.9.4.   Strategic outlook

9.9.5.   SWOT analysis

9.10. Sartorius Stedim Biotech Group

9.10.1. Business overview

9.10.2. Financial data

9.10.3. Product landscape

9.10.4. Strategic outlook

9.10.5. SWOT analysis

9.11. Solaris Biotech Solutions

9.11.1. Business overview

9.11.2. Financial data

9.11.3. Product landscape

9.11.4. Strategic outlook

9.11.5. SWOT analysis

9.12. Thermo Fisher Scientific Inc.

9.12.1. Business overview

9.12.2. Financial data

9.12.3. Product landscape

9.12.4. Strategic outlook

9.12.5. SWOT analysis

Data Tables

TABLE 1.          Europe market estimates by country, (USD Mn), 2014 - 2018

TABLE 2.          Europe market forecast by country, (USD Mn), 2019 - 2025

TABLE 3.          Europe market estimates by cell, (USD Mn), 2014 - 2018

TABLE 4.          Europe market forecast by cell, (USD Mn), 2019 - 2025

TABLE 5.          Europe market estimates by molecule, (USD Mn), 2014 - 2018

TABLE 6.          Europe market forecast by molecule, (USD Mn), 2019 - 2025

TABLE 7.          Europe market estimates by technology, (USD Mn), 2014 - 2018

TABLE 8.          Europe market forecast by technology, (USD Mn), 2019 - 2025

TABLE 9.          Europe market estimates by end-use, (USD Mn), 2014 - 2018

TABLE 10.        Europe market forecast by end-use, (USD Mn), 2019 - 2025

TABLE 11.        Competition review

TABLE 12.        Europe mammalian cells market estimates, (USD Mn), 2014 - 2018

TABLE 13.        Europe mammalian cells market forecast, (USD Mn), 2019 - 2025

TABLE 14.        Europe bacterial cells market estimates, (USD Mn), 2014 - 2018

TABLE 15.        Europe bacterial cells market forecast, (USD Mn), 2019 - 2025

TABLE 16.        Europe yeast cells market estimates, (USD Mn), 2014 – 2018

TABLE 17.        Europe yeast cells market forecast, (USD Mn), 2019 - 2025

TABLE 18.        Europe others market estimates, (USD Mn), 2014 – 2018

TABLE 19.        Europe others market forecast, (USD Mn), 2019 - 2025

TABLE 20.        Europe monoclonal antibodies market estimates, (USD Mn), 2014 - 2018

TABLE 21.        Europe monoclonal antibodies market forecast, (USD Mn), 2019 – 2025

TABLE 22.        Europe vaccines market estimates, (USD Mn), 2014 - 2018

TABLE 23.        Europe vaccines market forecast, (USD Mn), 2019 - 2025

TABLE 24.        Europe recombinant protein market estimates, (USD Mn), 2014 - 2018

TABLE 25.        Europe recombinant protein market forecast, (USD Mn), 2019 - 2025

TABLE 26.        Europe stem cell market estimates, (USD Mn), 2014 - 2018

TABLE 27.        Europe stem cell market forecast, (USD Mn), 2019 - 2025

TABLE 28.        Europe gene therapy market estimates, (USD Mn), 2014 - 2018

TABLE 29.        Europe gene therapy market forecast, (USD Mn), 2019 - 2025

TABLE 30.        Europe others market estimates, (USD Mn), 2014 - 2018

TABLE 31.        Europe others market forecast, (USD Mn), 2019 - 2025

TABLE 32.        Europe wave-induced motion SUB market estimates, (USD Mn), 2014 - 2018

TABLE 33.        Europe wave-induced motion SUB market forecast, (USD Mn), 2019 – 2025

TABLE 34.        Europe stirred SUB market estimates, (USD Mn), 2014 – 2018

TABLE 35.        Europe stirred SUB market forecast, (USD Mn), 2019 – 2025

TABLE 36.        Europe stirred-use bubble column market estimates, (USD Mn), 2014 - 2018

TABLE 37.        Europe stirred-use bubble column market forecast, (USD Mn), 2019 - 2025

TABLE 38.        Europe others market estimates, (USD Mn), 2014 - 2018

TABLE 39.        Europe others market forecast, (USD Mn), 2019 - 2025

TABLE 40.        Europe research and development (R&D) organizations market estimates, (USD Mn), 2014 - 2018

TABLE 41.        Europe research and development (R&D) organizations market forecast, (USD Mn), 2019 - 2025

TABLE 42.        Europe biopharma manufacturers market estimates, (USD Mn), 2014 - 2018

TABLE 43.        Europe biopharma manufacturers market forecast, (USD Mn), 2019 - 2025

TABLE 44.        Europe contract manufacturing organizations (CMOs) market estimates, (USD Mn), 2014 - 2018

TABLE 45.        Europe contract manufacturing organizations (CMOs) market forecast, (USD Mn), 2019 - 2025

TABLE 46.        Germany bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 47.        Germany bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 48.        Germany market size by cell, (USD Million), 2014 - 2018

TABLE 49.        Germany market size by cell, (USD Million), 2019 – 2025

TABLE 50.        Germany market size by molecule, (USD Million), 2014 - 2018

TABLE 51.        Germany market size by molecule, (USD Million), 2019 – 2025

TABLE 52.        Germany market size by technology, (USD Million), 2014 - 2018

TABLE 53.        Germany market size by technology, (USD Million), 2019 – 2025

TABLE 54.        Germany market size by end-use, (USD Million), 2014 - 2018

TABLE 55.        Germany market size by end-use, (USD Million), 2019 – 2025

TABLE 56.        UK bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 57.        UK bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 58.        UK market size by cell, (USD Million), 2014 - 2018

TABLE 59.        UK market size by cell, (USD Million), 2019 – 2025

TABLE 60.        UK market size by molecule, (USD Million) 2014 - 2018

TABLE 61.        UK market size by molecule, (USD Million), 2019 – 2025

TABLE 62.        UK market size by technology, (USD Million), 2014 - 2018

TABLE 63.        UK market size by technology, (USD Million), 2019 – 2025

TABLE 64.        UK market size by end-use, (USD Million), 2014 - 2018

TABLE 65.        UK market size by end-use, (USD Million), 2019 – 2025

TABLE 66.        Spain bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 67.        Spain bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 68.        Spain market size by cell, (USD Million), 2014 - 2018

TABLE 69.        Spain market size by cell, (USD Million), 2019 – 2025

TABLE 70.        Spain market size by molecule, (USD Million) 2014 - 2018

TABLE 71.        Spain market size by molecule, (USD Million), 2019 – 2025

TABLE 72.        Spain market size by technology, (USD Million), 2014 - 2018

TABLE 73.        Spain market size by technology, (USD Million), 2019 – 2025

TABLE 74.        Spain market size by end-use, (USD Million), 2014 - 2018

TABLE 75.        Spain market size by end-use, (USD Million), 2019 – 2025

TABLE 76.        Italy bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 77.        Italy bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 78.        Italy market size by cell, (USD Million), 2014 - 2018

TABLE 79.        Italy market size by cell, (USD Million), 2019 – 2025

TABLE 80.        Italy market size by molecule, (USD Million) 2014 - 2018

TABLE 81.        Italy market size by molecule, (USD Million), 2019 – 2025

TABLE 82.        Italy market size by technology, (USD Million), 2014 - 2018

TABLE 83.        Italy market size by technology, (USD Million), 2019 – 2025

TABLE 84.        Italy market size by end-use, (USD Million), 2014 - 2018

TABLE 85.        Italy market size by end-use, (USD Million), 2019 – 2025

TABLE 86.        France bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 87.        France bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 88.        France market size by cell, (USD Million), 2014 - 2018

TABLE 89.        France market size by cell, (USD Million), 2019 – 2025

TABLE 90.        France market size by molecule, (USD Million) 2014 - 2018

TABLE 91.        France market size by molecule, (USD Million), 2019 – 2025

TABLE 92.        France market size by technology, (USD Million), 2014 - 2018

TABLE 93.        France market size by technology, (USD Million), 2019 – 2025

TABLE 94.        France market size by end-use, (USD Million), 2014 - 2018

TABLE 95.        France market size by end-use, (USD Million), 2019 – 2025

TABLE 96.        The Netherlands bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 97.        The Netherlands bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 98.        The Netherlands market size by cell, (USD Million), 2014 - 2018

TABLE 99.        The Netherlands market size by cell, (USD Million), 2019 – 2025

TABLE 100.      The Netherlands market size by molecule, (USD Million) 2014 - 2018

TABLE 101.      The Netherlands market size by molecule, (USD Million), 2019 – 2025

TABLE 102.      The Netherlands market size by technology, (USD Million), 2014 - 2018

TABLE 103.      The Netherlands market size by technology, (USD Million), 2019 – 2025

TABLE 104.      The Netherlands market size by end-use, (USD Million), 2014 - 2018

TABLE 105.      The Netherlands market size by end-use, (USD Million), 2019 – 2025

TABLE 106.      Denmark bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 107.      Denmark bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 108.      Denmark market size by cell, (USD Million), 2014 - 2018

TABLE 109.      Denmark market size by cell, (USD Million), 2019 – 2025

TABLE 110.      Denmark market size by molecule, (USD Million) 2014 - 2018

TABLE 111.      Denmark market size by molecule, (USD Million), 2019 – 2025

TABLE 112.      Denmark market size by technology, (USD Million), 2014 - 2018

TABLE 113.      Denmark market size by technology, (USD Million), 2019 – 2025

TABLE 114.      Denmark market size by end-use, (USD Million), 2014 - 2018

TABLE 115.      Denmark market size by end-use, (USD Million), 2019 – 2025

TABLE 116.      Russia bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 117.      Russia bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 118.      Russia market size by cell, (USD Million), 2014 - 2018

TABLE 119.      Russia market size by cell, (USD Million), 2019 – 2025

TABLE 120.      Russia market size by molecule, (USD Million) 2014 - 2018

TABLE 121.      Russia market size by molecule, (USD Million), 2019 – 2025

TABLE 122.      Russia market size by technology, (USD Million), 2014 - 2018

TABLE 123.      Russia market size by technology, (USD Million), 2019 – 2025

TABLE 124.      Russia market size by end-use, (USD Million), 2014 - 2018

TABLE 125.      Russia market size by end-use, (USD Million), 2019 – 2025

TABLE 126.      Poland bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 127.      Poland bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 128.      Poland market size by cell, (USD Million), 2014 - 2018

TABLE 129.      Poland market size by cell, (USD Million), 2019 – 2025

TABLE 130.      Poland market size by molecule, (USD Million) 2014 - 2018

TABLE 131.      Poland market size by molecule, (USD Million), 2019 – 2025

TABLE 132.      Poland market size by technology, (USD Million), 2014 - 2018

TABLE 133.      Poland market size by technology, (USD Million), 2019 – 2025

TABLE 134.      Poland market size by end-use, (USD Million), 2014 - 2018

TABLE 135.      Poland market size by end-use, (USD Million), 2019 – 2025

TABLE 136.      Sweden bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 137.      Sweden bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 138.      Sweden market size by cell, (USD Million), 2014 - 2018

TABLE 139.      Sweden market size by cell, (USD Million), 2019 – 2025

TABLE 140.      Sweden market size by molecule, (USD Million) 2014 - 2018

TABLE 141.      Sweden market size by molecule, (USD Million), 2019 – 2025

TABLE 142.      Sweden market size by technology, (USD Million), 2014 - 2018

TABLE 143.      Sweden market size by technology, (USD Million), 2019 – 2025

TABLE 144.      Sweden market size by end-use, (USD Million), 2014 - 2018

TABLE 145.      Sweden market size by end-use, (USD Million), 2019 – 2025

TABLE 146.      Norway bioreactors market estimates, (USD Mn), 2014 - 2018

TABLE 147.      Norway bioreactors market forecast, (USD Mn), 2019 - 2025

TABLE 148.      Norway market size by cell, (USD Million), 2014 - 2018

TABLE 149.      Norway market size by cell, (USD Million), 2019 – 2025

TABLE 150.      Norway market size by molecule, (USD Million) 2014 - 2018

TABLE 151.      Norway market size by molecule, (USD Million), 2019 – 2025

TABLE 152.      Norway market size by technology, (USD Million), 2014 - 2018

TABLE 153.      Norway market size by technology, (USD Million), 2019 – 2025

TABLE 154.      Norway market size by end-use, (USD Million), 2014 - 2018

TABLE 155.      Norway market size by end-use, (USD Million), 2019 – 2025

 

Charts & Figures

FIG 1.     Industry segmentation

FIG 2.     Europe bioreactors industry outlook, 2014 - 2025

FIG 3.     Porter’s analysis

FIG 4.     PEST analysis

Select License

Europe Bioreactors Market Share, Size Analysis | Report 2019-24


Related Reports
Why Choose us?